August 2026 Research Update

This month added a clearer, more practical picture of how to measure cognition in Kabuki syndrome type 1 (KS1) in a consistent way. In a small group of adolescents and adults, the biggest and most consistent difficulty was in visuospatial skills (skills like recognizing patterns and copying shapes), while language and executive skills varied more from person to person. Several specific visuospatial and attention tasks also gave very similar results when repeated, which is important if researchers want to track changes over time. [1]

The study tested a Kabuki Syndrome Cognitive Assessment Battery (KS-CAB) twice on consecutive days in 22 people with molecularly confirmed KS1, and found high repeatability for multiple visuospatial measures. Some tasks had important practical limits, such as a floor effect where several participants scored at the very bottom on one visuospatial test, making it less useful for tracking change in those individuals. The authors highlighted a short list of candidate measures that may work best as outcome measures in future KS1 studies. [1]

The same work also reported a genotype-related pattern within KS1: people with missense variants tended to perform better on certain visuospatial tasks than people with truncating variants. This does not explain an individual person's abilities, but it adds to the idea that different genetic changes within KMT2D can be linked with different average cognitive profiles in groups. [1]

For patients and caregivers, this mainly matters as research infrastructure: it identifies cognitive tasks that appear steady enough to be used as reliable measurements in future KS1 clinical studies, rather than relying on tests that change a lot from day to day. It also reinforces that visuospatial skills may be a particularly prominent challenge for many adolescents and adults with KS1, which could help explain why some school or daily tasks feel harder than others. What remains uncertain is how well these findings apply to younger children, to more diverse KS1 groups, or to people with Kabuki syndrome not caused by KMT2D, since this was a small KS1-only sample. [1]

This month, lab and animal research focused on what Kabuki-related genes do in the body, pointing to two connected ideas: these genes help cells handle physical stress, and they also influence early development pathways that shape the face, immune organs, and major blood vessels. These studies do not test treatments in people, but they help explain why a single gene change can have effects in multiple organs. The overall message is that Kabuki syndrome biology may involve both how cells cope with strain and how developing tissues coordinate growth signals. [2] [3]

One cellular study focused on MLL4 (also called KMT2D) and reported that it can form "condensates" (clusters of proteins and DNA-related material) that respond to mechanical forces inside the nucleus. When MLL4 function was lost in a Kabuki syndrome context, the study described ongoing nuclear envelope rupture, which then activated the cGAS-STING pathway (an innate immune alarm system inside cells) and led to programmed cell death. In plain terms, the work proposes a chain from weakened nuclear protection under physical stress to an internal danger signal turning on. [2]

A separate mouse study examined how reduced Kmt2d function interacts with Tbx1 changes, because TBX1 is central to a different genetic condition (22q11.2 deletion syndrome) that can share some developmental features. In mice with both changes in the TBX1 lineage, researchers reported perinatal lethality and a range of craniofacial, thymus/parathyroid, and aortic arch defects, along with broad decreases in gene activity in pathways related to transcription, the cell cycle, and signaling. In plain language, this suggests these conditions can converge on shared developmental programs, which may help explain overlapping patterns of organ involvement across different syndromes. [3]

For families, these studies mainly add biological explanation rather than immediate clinical change. The cell study connects KMT2D loss to cell stress responses and an internal immune alarm pathway, which could matter later if future work shows the same process in patient tissues and finds safe ways to modify it. The mouse study supports the idea that Kabuki-related genes can intersect with other developmental gene networks that shape the face, immune-related organs, and major arteries, but it does not show what will happen in any individual child or adult with Kabuki syndrome. What remains uncertain is how directly these lab and animal findings map onto day-to-day symptoms in people, and which parts (if any) become targets for future therapies. [2] [3]